Patent foramen ovale and stroke: Rethinking the need for systematic transesophageal echocardiography

Minerva Medica

Volumn 103, Issue 5, 2012, Pages 413-414

  Martin M ^a   Secades, S ^a   Campos, A G ^a   Corros, C ^a   Rodriguez M L ^a   De La Hera, J M ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

AORTA ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LETTER; MALE; PATENT FORAMEN OVALE; SMOKING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

BRAIN ISCHEMIA; FORAMEN OVALE, PATENT; HEART ANEURYSM; HUMANS; STROKE;

EID: 84871793851     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Larrue V, Massabuau P. Patent foramen ovale and ischemic stroke. Minerva Medica 2012;103:199-200.
2. Meier B, Frank B, Wahl A, Diener HC. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. European Heart Journal 2012;33:705-13.
3. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW et al. and Closure I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991-9.
4. Gu X, He Y, Li Z, Kontos MC, Paulsen WH, Arrowood JA, Nixon JV. Comparison of frequencies of patent foramen ovale and thoracic aortic atherosclerosis in patients with cryptogenic ischemic stroke undergoing transesophageal echocardiography. Am J Cardiol 2011;108:1815-9.